These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11374329)

  • 1. Treatment regimen and hypnotic self-administration.
    Roehrs T; Bonahoom A; Pedrosi B; Rosenthal L; Roth T
    Psychopharmacology (Berl); 2001 Apr; 155(1):11-7. PubMed ID: 11374329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nighttime versus daytime hypnotic self-administration.
    Roehrs T; Bonahoom A; Pedrosi B; Zorick F; Roth T
    Psychopharmacology (Berl); 2002 May; 161(2):137-42. PubMed ID: 11981593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypnotic self administration and dose escalation.
    Roehrs T; Pedrosi B; Rosenthal L; Roth T
    Psychopharmacology (Berl); 1996 Sep; 127(2):150-4. PubMed ID: 8888381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypnotic self administration: forced-choice versus single-choice.
    Roehrs T; Pedrosi B; Rosenthal L; Zorick F; Roth T
    Psychopharmacology (Berl); 1997 Sep; 133(2):121-6. PubMed ID: 9342777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twelve months of nightly zolpidem does not lead to dose escalation: a prospective placebo-controlled study.
    Roehrs TA; Randall S; Harris E; Maan R; Roth T
    Sleep; 2011 Feb; 34(2):207-12. PubMed ID: 21286241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rebound insomnia after hypnotic withdrawal in insomniac outpatients.
    Hajak G; Clarenbach P; Fischer W; Rodenbeck A; Bandelow B; Broocks A; Rüther E
    Eur Arch Psychiatry Clin Neurosci; 1998; 248(3):148-56. PubMed ID: 9728734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rebound insomnia and hypnotic self administration.
    Roehrs T; Merlotti L; Zorick F; Roth T
    Psychopharmacology (Berl); 1992; 107(4):480-4. PubMed ID: 1603890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative 25-night sleep laboratory study on the effects of quazepam and triazolam on chronic insomniacs.
    Mamelak M; Csima A; Price V
    J Clin Pharmacol; 1984; 24(2-3):65-75. PubMed ID: 6143767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of an every-other-night regimen in insomniac patients: subjective hypnotic effectiveness of quazepam, triazolam, and placebo.
    Scharf MB
    J Clin Psychiatry; 1993 Jan; 54(1):33-8. PubMed ID: 8428895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of the chronic administration of triazolam 0.50 mg on the sleep of insomniacs].
    Stepanski E; Zorick F; Kaffeman M; Sicklesteel J; Roth T
    Nouv Presse Med; 1982 Oct; 11(40):2987-90. PubMed ID: 6128721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethanol as a hypnotic in insomniacs: self administration and effects on sleep and mood.
    Roehrs T; Papineau K; Rosenthal L; Roth T
    Neuropsychopharmacology; 1999 Mar; 20(3):279-86. PubMed ID: 10063488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disturbed sleep predicts hypnotic self-administration.
    Roehrs T; Bonahoom A; Pedrosi B; Rosenthal L; Roth T
    Sleep Med; 2002 Jan; 3(1):61-6. PubMed ID: 14592256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the hypnotic activity of triazolam, flurazepam hydrochloride, and placebo.
    Sunshine A
    Clin Pharmacol Ther; 1975 May; 17(5):573-7. PubMed ID: 236108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of zopiclone and triazolam in the treatment of geriatric insomniacs.
    Elie R; Frenay M; Le Morvan P; Bourgouin J
    Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():39-46. PubMed ID: 2201729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of gradual withdrawal on the rebound sleep disorder after discontinuation of triazolam.
    Greenblatt DJ; Harmatz JS; Zinny MA; Shader RI
    N Engl J Med; 1987 Sep; 317(12):722-8. PubMed ID: 3306380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Halcion (triazolam) in the treatment of insomnia].
    Muzychenko AP; Prokudin VN; Bogdan AN
    Ter Arkh; 1997; 69(1):65-8. PubMed ID: 9163057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperarousal in insomnia and hypnotic dose escalation.
    Roehrs TA; Roth T
    Sleep Med; 2016 Jul; 23():16-20. PubMed ID: 27692272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of different doses of triazolam in the middle-of-the-night insomnia: a double-blind, randomized, parallel group study.
    Ferini Strambi L; Marelli S; Zucconi M; Galbiati A; Biggio G
    J Neurol; 2017 Jul; 264(7):1362-1369. PubMed ID: 28584913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of triazolam and chloral hydrate in geriatric insomniacs.
    Piccione P; Zorick F; Lutz T; Grissom T; Kramer M; Roth T
    J Int Med Res; 1980; 8(5):361-7. PubMed ID: 6106611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam).
    Saletu B; Anderer P; Brandstätter N; Frey R; Grünberger J; Klösch G; Mandl M; Wetter T; Zeitlhofer J
    Neuropsychobiology; 1994; 29(2):69-90. PubMed ID: 8170529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.